BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35703127)

  • 41. Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers.
    Santo L; Siu KT; Raje N
    Semin Oncol; 2015 Dec; 42(6):788-800. PubMed ID: 26615126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Negative regulators of cyclin-dependent kinases and their roles in cancers.
    Lee MH; Yang HY
    Cell Mol Life Sci; 2001 Nov; 58(12-13):1907-22. PubMed ID: 11766887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclins and cell cycle checkpoints.
    Johnson DG; Walker CL
    Annu Rev Pharmacol Toxicol; 1999; 39():295-312. PubMed ID: 10331086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
    Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
    Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells.
    Arooz T; Yam CH; Siu WY; Lau A; Li KK; Poon RY
    Biochemistry; 2000 Aug; 39(31):9494-501. PubMed ID: 10924145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Revisiting the "Cdk-centric" view of the mammalian cell cycle.
    Malumbres M
    Cell Cycle; 2005 Feb; 4(2):206-10. PubMed ID: 15655365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer.
    MacLachlan TK; Sang N; Giordano A
    Crit Rev Eukaryot Gene Expr; 1995; 5(2):127-56. PubMed ID: 8845581
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors.
    Pavletich NP
    J Mol Biol; 1999 Apr; 287(5):821-8. PubMed ID: 10222191
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6.
    Schulze-Gahmen U; Jung JU; Kim SH
    Structure; 1999 Mar; 7(3):245-54. PubMed ID: 10368294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell-cycle control and its watchman.
    Jacks T; Weinberg RA
    Nature; 1996 Jun; 381(6584):643-4. PubMed ID: 8649505
    [No Abstract]   [Full Text] [Related]  

  • 52. Expressions of cell cycle regulators in human colorectal cancer cell lines.
    Tominaga O; Nita ME; Nagawa H; Fujii S; Tsuruo T; Muto T
    Jpn J Cancer Res; 1997 Sep; 88(9):855-60. PubMed ID: 9369933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cdks, cyclins and CKIs: roles beyond cell cycle regulation.
    Lim S; Kaldis P
    Development; 2013 Aug; 140(15):3079-93. PubMed ID: 23861057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications.
    Sofi S; Mehraj U; Qayoom H; Aisha S; Asdaq SMB; Almilaibary A; Mir MA
    Med Oncol; 2022 Apr; 39(6):106. PubMed ID: 35486263
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p21-dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclin-dependent kinases.
    Ukomadu C; Dutta A
    J Biol Chem; 2003 Oct; 278(44):43586-94. PubMed ID: 12930830
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Living with or without cyclins and cyclin-dependent kinases.
    Sherr CJ; Roberts JM
    Genes Dev; 2004 Nov; 18(22):2699-711. PubMed ID: 15545627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative evaluation of the expression of cell cycle regulating proteins: cyclin D1, P53 and P21 (WAF1) in colorectal cancer.
    Pasz-Walczak G; Kordek R
    Pol J Pathol; 2000; 51(2):63-9. PubMed ID: 10974928
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural dissection of cyclin dependent kinases regulation and protein recognition properties.
    Lolli G
    Cell Cycle; 2010 Apr; 9(8):1551-61. PubMed ID: 20372077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclins and related kinases in cancer cells.
    Malumbres M
    J BUON; 2007 Sep; 12 Suppl 1():S45-52. PubMed ID: 17935277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclin-dependent kinases and cell-cycle transitions: does one fit all?
    Hochegger H; Takeda S; Hunt T
    Nat Rev Mol Cell Biol; 2008 Nov; 9(11):910-6. PubMed ID: 18813291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.